Yahoo Web Search

Search results

1. Avalo Therapeutics, Inc.

   NasdaqCM: AVTX

   10.82

   Add to watchlist

   Sign in to add to watchlist

   Sign In

   -0.03 (-0.28%)

   At close: Mon. May 13, 2024 4:00 PM EDT · Nasdaq Real Time Price (USD) · Market closed

   Full chart

   • 1D
   • 5D
   • 1M
   • 6M
   • YTD
   • 1Y
   • MAX

   • Open	10.66
     High	11.20
     Low	10.63

   • Mkt Cap	11.19M
     P/E (TTM)	N/A
     Div & Yield	N/A & N/A

   • Prev. Close	10.85
     52 Wk. Low	3.95
     52 Wk. High	1,130.40

   More about AVTX

   Top stories

   • ANGO
     +1.16%
   • AVTX
     -0.28%

   Oppenheimer Predicts Over 100% Rally for These 2 Healthcare Stocks

   Yahoo Finance · 2 weeks ago

   

   Related stocks

   • TPST
     Tempest Therapeutics, Inc.
     TPST
     3.2800
     +0.92%
   • ZVSA
     ZyVersa Therapeutics, Inc.
     ZVSA
     5.46
     +1.68%
   • NVOS
     Novo Integrated Sciences, Inc.
     NVOS
     0.5750
     -1.03%
   • LIFW
     MSP Recovery, Inc.
     LIFW
     0.8080
     -5.42%
   • FEMY
     Femasys Inc.
     FEMY
     1.2700
     +4.96%

   More on Yahoo Finance

2. www.zacks.com › stock › quoteAvalo Therapeutics - AVTX - Stock Price Today - Zacks

   www.zacks.com › stock › quote

   • Cached

   5 days ago · View Avalo Therapeutics, Inc AVTX investment & stock information. Get the latest Avalo Therapeutics, Inc AVTX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

3. finance.yahoo.com › news › avalo-reports-firstAvalo Reports First Quarter 2024 Financial Results and ...

   finance.yahoo.com › news › avalo-reports-first

   • Cached

   1 day ago · Topline results from planned Phase 2 trial of AVTX-009 in hidradenitis suppurativa expected in 2026Cash on hand of approximately $110 million as of March 31, 2024 with expected cash runway into ...

4. markets.businessinsider.com › news › stocksAvalo Reports First Quarter 2024 Financial Results and ...

   markets.businessinsider.com › news › stocks

   • Cached

   1 day ago · WAYNE, Pa. and ROCKVILLE, Md., May 13, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), today announced business updates and financial results for the first quarter of 2024 ...

5. ir.avalotx.com › press-releases › detailAvalo Reports First Quarter 2024 Financial Results and ...

   ir.avalotx.com › press-releases › detail

   • Cached

   1 day ago · Topline results from planned Phase 2 trial of AVTX-009 in hidradenitis suppurativa expected in 2026 Cash on hand of approximately $110 million as of March 31, 2024 with expected cash runway into 2027 WAYNE, Pa. and ROCKVILLE, Md., May 13, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), today announced business updates and ...

6. seekingalpha.com › news › 4105063-avalo-therapeuticsAvalo Therapeutics reports Q1 results (NASDAQ:AVTX)

   seekingalpha.com › news › 4105063-avalo-therapeutics

   18 hours ago · May 13, 2024 8:05 AM ET Avalo Therapeutics, Inc. (AVTX) Stock By: Deepa Sarvaiya, SA News Editor. Avalo Therapeutics press release ( NASDAQ: AVTX ): Q1 net loss of $121.3 million. Cash on hand of ...

7. www.marketscreener.com › quote › stockAvalo Reports First Quarter 2024 Financial Results and ...

   www.marketscreener.com › quote › stock

   • Cached

   19 hours ago · Cash on hand of approximately $110 million as of March 31, 2024 with expected cash runway into 2027. WAYNE, Pa. and ROCKVILLE, Md., May 13, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), today announced business updates and financial results for the first quarter of 2024. “Over the past month we have made considerable ...

8. stockanalysis.com › stocks › avtxAvalo Therapeutics, Inc. (AVTX) Stock Price, Quote & News ...

   stockanalysis.com › stocks › avtx

   • Cached

   6 days ago · As AVTX stock price soars, Avalo Therapeutics bankruptcy remains. Avalo Therapeutics (NASDAQ: AVTX) stock price has become unloved and unwanted in the past few months. It has become a penny stock as it is trading at $0.1630, down from its all-time high of $91.65. 8 months ago - Invezz.